The FN1-ITGB4 Axis Drives Acquired Chemoresistance in Bladder Cancer by Activating FAK Signaling
Oncology Research · 2026
DOI: 10.32604/or.2025.072084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Xiaoyu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Urinary Bladder Neoplasms, Fibronectins, Integrin beta4. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Department of Ultrasound, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Zitieren
APA
Zhang, X., Zong, R., Sun, Y., Chen, N., Zhu, K., Tong, H., Li, T., Zhu, J., Qin, Z., Wu, L., Wang, A., & He, W. (2026). The FN1-ITGB4 Axis Drives Acquired Chemoresistance in Bladder Cancer by Activating FAK Signaling. Oncology Research. https://doi.org/10.32604/or.2025.072084
Vancouver
Zhang X, Zong R, Sun Y, Chen N, Zhu K, Tong H, et al. The FN1-ITGB4 Axis Drives Acquired Chemoresistance in Bladder Cancer by Activating FAK Signaling. Oncology Research. 2026. doi:10.32604/or.2025.072084
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaoyu and Zong, RenFei and Sun, Yan and Chen, Nan and Zhu, Kunyao and Tong, Hang and Li, Tinghao and Zhu, Junlong and Qin, Zijia and Wu, Linfeng and Wang, Aimin and He, Weiyang},
title = {The FN1-ITGB4 Axis Drives Acquired Chemoresistance in Bladder Cancer by Activating FAK Signaling},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2025.072084}
}
EUVIMED